Purchase Order 75N91022P00868

The Department of Health and Human Services Food and Drug Administration awarded a $320,560 firm fixed price purchase order to Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, to procure 150 glass pathology slides stained with hematoxylin and eosin from triple negative breast cancer patients within the last seven years. The slides are being acquired under solicitation CDRH-2023-118641 to support the agency's efforts to create datasets that validate digital...

This federal contract award to Cancer Diagnostics, Inc. (CDI) was issued by the Defense Health Agency (DHA) for the provision of medical supplies and reagents, including tissue marking dye, Auto Frost hydrophobic microscope slides, and other materials to support gross specimen processing and anatomical pathology labs. The contract is a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price pricing type, and a potential value of $102,434.50. The contract does not have a set-aside...

This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency to Cancer Diagnostics, Inc. (CDI) for the procurement of Auto Frost IHC microscope slides and various other materials needed to support the Anatomic Pathology Lab at the Walter Reed Medical Center. The one-year contract is a firm fixed-price agreement with a ceiling value of $101,000.00. CDI is a for-profit manufacturer and supplier of products for the anatomic pathology and histology...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Biopartners, Inc. for the TSS CPTAC DIGITAL MEDICAL IMAGES OF CPTAC BIOSPECIMENS project. The contract has a ceiling value of $12,240.00 and an ultimate completion date of September 17, 2018. It is part of the Tissue Source Site for Tumor Analysis master IDIQ contract. The contract does not have a set-aside designation. The award supports the NCI's Medical Images for CPTAC Biospecimens program.

This is a $259,047 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Exact Sciences Corporation for the provision of Oncotype DX Breast CPT 81519 diagnostic testing services. The contract was awarded under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. This contract has no set-aside designation. Exact Sciences Corporation, a for-profit medical technology company specializing in advanced diagnostic testing services for...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics Inc., a self-certified HUBZone joint venture medical equipment manufacturer, for the provision of $124,537.50 worth of test slides, acetaminophen product. The contract does not have a set-aside designation. Ortho-Clinical Diagnostics Inc. has provided various medical equipment, reagents, consumables, and testing services to federal agencies such as the...

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie (Centrum Onkologii) in Poland. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ, with a ceiling value of $336,000.00 and a period of performance ending on September 30, 2014. The contract is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA)...

This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of TYROSEQ V.2 MOLECULAR TESTING services. The $150,000.00 firm fixed price purchase order was issued by the Defense Health Agency and does not have a set-aside designation. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer screening and diagnosis utilizing next generation genomic sequencing under...

This is a $98,100.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Asterand US Acquisition Corporation, a for-profit organization. The contract is under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract vehicle and is set aside for small businesses. The purpose of the contract is to provide tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. The ultimate completion date for the contract is August...